Dow Up 0.11% Nasdaq Up 0.50%

Salix Pharmaceuticals Ltd. (SLXP)

-NasdaqGS
159.11 0.45(0.28%) Aug 29, 4:00PM EDT
Prev Close:158.66
Open:159.17
Bid:155.42 x 600
Ask:N/A
1y Target Est:158.38
Beta:1.14
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:158.15 - 161.28
52wk Range:65.14 - 162.38
Volume:740,067
Avg Vol (3m):1,301,760
Market Cap:10.13B
P/E (ttm):135.18
EPS (ttm):1.18
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SLXPUp 0.28%10.13B
BAYRY111.06B
GSK117.94B
WCRXN/A

Key Statistics

Forward P/E (1 yr):22.80
P/S (ttm):8.01
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :6.17
Quarterly EPS Est (Sep-14) :1.56
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.34

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs and medical devices to treat various gastrointestinal diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback